Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed: 4,797
Companies: 1,769
Pipeline programs: 20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources

Quick answer

human heterologous liver cells

human insulin (rdna)

human normal immunoglobulin

human normal immunoglobulin (ivig)

human normal immunoglobulin (scig)

huolingshengji

ibalizumab

ibalizumab-uiyk

ibutilide fumarate

idelalisib

imeglimin hydrochloride

imlifidase

inavolisib

inclisiran

inclisiran sodium

incobotulinumtoxina

indium in-111 oxyquinoline

inebilizumab

inebilizumab-cdon

infliximab

infliximab-abda

infliximab-axxq

infliximab-dyyb

infliximab-qbtx

Frequently asked questions